Expression of NPAT, a novel substrate of cyclin E–CDK2, promotes S-phase entry

  1. Jiyong Zhao,
  2. Brian Dynlacht,
  3. Takashi Imai,
  4. Tada-aki Hori, and
  5. Ed Harlow
  1. Laboratory of Molecular Oncology, Massachusetts General Hospital (MGH) Cancer Center, Charlestown, Massachusetts 02129 USA; Genome Research Group, National Institute of Radiological Science, Inage-ku, Chiba 263, Japan

Abstract

To understand the mechanisms by which CDKs regulate cell cycle progression, it is necessary to identify and characterize the physiological substrates of these kinases. We have developed a screening method to identify novel CDK substrates. One of the cDNAs identified in the screen is identical to the recently isolatedNPAT gene. Here we show that NPAT associates with cyclin E–CDK2 in vivo and can be phosphorylated by this CDK. The protein level of NPAT peaks at the G1/S boundary. Overexpression of NPAT accelerates S-phase entry, and this effect is enhanced by coexpression of cyclin E–CDK2. These results suggest that NPAT is a substrate of cyclin E–CDK2 and plays a role in S-phase entry.

Keywords

Footnotes

  • Present address: Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138 USA.

  • Corresponding author.

  • E-MAIL zhao{at}helix.mgh.harvard.edu; FAX (617) 726-7808.

    • Received November 25, 1997.
    • Accepted January 7, 1998.
| Table of Contents

Life Science Alliance